Lobbying Activity Report

4636-42761

Organization: Apotex Inc.
Associated registration: 10049-4636-5
Lobbying Activity date: 2025-05-23
Arranged a meeting: No
Posted date: 2025-06-11

In-house lobbyists who participated in the lobbying activity: Matthew Southcott
Chris Fournier
Senior Public Office Holders who were lobbied in this activity: Sue Bouma, Executive Director, Clinical Services & Evaluation
Pharmaceutical, Laboratory & Blood Services Division, Health

John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement Branch, Health

Tijana Fazlagic, Executive Director, Therapeutic Assessment&Access
PharmaCare Benefits Branch, Health

Sarah Pugh, Executive Director
Integrated Health Services, Planning& Systems, Health

Ian Rongve, Assistant Deputy Minister
Pharmaceutical, Laboratory & Blood Services Division, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Ongoing interactions related to increased and sustainable utilization of cost-saving generic and biosimilar medicines, and a predictable and viable business environment for generic medicines.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Government Procurement, Health
 
Senior officer who filed this Lobbying Activity Report: Raymond Shelley
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Return to Registration for Western Canada Wilderness Committee
Date Modified: